Next Article in Journal
Risk of Cancers in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results from the Korea National Health Insurance Claims Database 2010–2018
Next Article in Special Issue
Urinary Biomarkers α-GST and π-GST for Evaluation and Monitoring in Living and Deceased Donor Kidney Grafts
Previous Article in Journal
A Systematic Summary of Systematic Reviews on Anticoagulant Therapy in Sepsis
Previous Article in Special Issue
Validation of Identified Susceptible Gene Variants for New-Onset Diabetes in Renal Transplant Recipients
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 8
Issue 11
10.3390/jcm8111870
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to J. Clin. Med. 2019, 8(5), 587.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Fast Tac Metabolizers at Risk—It is Time for a C/D Ratio Calculation. J. Clin. Med. 2019, 8, 587

by
Katharina Schütte-Nütgen
1,†,
Gerold Thölking
1,†,
Julia Steinke
1,
Hermann Pavenstädt
1,
René Schmidt
2,
Barbara Suwelack
1 and
Stefan Reuter
1,*
1
Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of Münster, 48149 Münster, Germany
2
Institute of Biostatistics and Clinical Research, University Hospital of Münster, 48149 Münster, Germany
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
J. Clin. Med. 2019, 8(11), 1870; https://doi.org/10.3390/jcm8111870
Submission received: 31 October 2019 / Accepted: 1 November 2019 / Published: 4 November 2019
(This article belongs to the Special Issue Recent Advances and Clinical Outcomes of Kidney Transplantation)
Versions Notes
The authors wish to make the following corrections to this paper [1].
The authors made an error regarding the rejection-free survival curve in Figure 4A. Figure 4 needs to be corrected.
Jcm 08 01870 i001
should be replaced with
Jcm 08 01870 i002
The authors apologize to the readers for any inconvenience caused by these changes. It is important to state that this correction do not affect our study’s results and involve no changes or modifications in the original data supporting our results. The original manuscript will remain online on the article webpage, with reference to this Correction.

Reference

  1. Schütte-Nütgen, K.; Thölking, G.; Steinke, J.; Pavenstädt, H.; Schmidt, R.; Suwelack, B.; Reuter, S. Fast Tac Metabolizers at Risk—It is Time for a C/D Ratio Calculation. J. Clin. Med. 2019, 8, 587. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Schütte-Nütgen, K.; Thölking, G.; Steinke, J.; Pavenstädt, H.; Schmidt, R.; Suwelack, B.; Reuter, S. Correction: Fast Tac Metabolizers at Risk—It is Time for a C/D Ratio Calculation. J. Clin. Med. 2019, 8, 587. J. Clin. Med. 2019, 8, 1870. https://doi.org/10.3390/jcm8111870

AMA Style

Schütte-Nütgen K, Thölking G, Steinke J, Pavenstädt H, Schmidt R, Suwelack B, Reuter S. Correction: Fast Tac Metabolizers at Risk—It is Time for a C/D Ratio Calculation. J. Clin. Med. 2019, 8, 587. Journal of Clinical Medicine. 2019; 8(11):1870. https://doi.org/10.3390/jcm8111870

Chicago/Turabian Style

Schütte-Nütgen, Katharina, Gerold Thölking, Julia Steinke, Hermann Pavenstädt, René Schmidt, Barbara Suwelack, and Stefan Reuter. 2019. "Correction: Fast Tac Metabolizers at Risk—It is Time for a C/D Ratio Calculation. J. Clin. Med. 2019, 8, 587" Journal of Clinical Medicine 8, no. 11: 1870. https://doi.org/10.3390/jcm8111870

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop